Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Therapeutics × Clear all

NCT01040026 2023-04-04

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Phase 1/2 Completed

Multiple Myeloma

NCT01892293 2019-01-10

CT Antigen TCR-Engineered T Cells for Myeloma

Phase 1/2 Terminated

6 enrolled 10 charts

Multiple Myeloma